# FDA EIR - UCB Pharma S.A. - February 04, 2022

Source: https://www.globalkeysolutions.net/records/eir/ucb-pharma-sa/c0412e1a-bd81-4e61-8d2c-6bc873ddb1ac

> FDA EIR for UCB Pharma S.A. on February 04, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: UCB Pharma S.A.
- Inspection Date: 2022-02-04
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2022-02-04](https://www.globalkeysolutions.net/records/483/ucb-pharma-sa/4d10a705-f62a-4e4d-a1a3-bc75539da471)
- [EIR - 2023-04-21](https://www.globalkeysolutions.net/records/eir/ucb-pharma-sa/0a4d5150-1f3d-4902-a9e3-98e6c80b367f)

## Related Officers

- [ Investigator, Consumer Safety Officer](https://www.globalkeysolutions.net/people/thuy-nguyen/1cfb5467-f0b7-49b8-85c1-00373692e35e)
- [Investigator](https://www.globalkeysolutions.net/people/roger-f-zabinski/87e05838-f8b5-489a-8db7-6669e68a2c2e)
- [Bo Chi](https://www.globalkeysolutions.net/people/bo-chi/9c83477d-58c1-4183-832e-ce8cbd25a521)
- [Senior Regulatory Specialist](https://www.globalkeysolutions.net/people/wayne-e-seifert/e92e1f10-c61e-4b08-9156-25907e5e2942)

Company: https://www.globalkeysolutions.net/companies/ucb-pharma-sa/6a03badf-6619-4125-b598-85ceebcc8c50

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c